Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Active, Not Recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions: Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

Emory University Atlanta, Georgia, United States

Karmanos Cancer Institute Detroit, Michigan, United States

R.J.Zuckerberg Cancer Center Lake Success, New York, United States

View all 13 locations

View Trial Details

Active, Not Recruiting

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

NCT04584008

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Carcinoma, +42 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors

NCT03454763

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy

View Trial Details

Active, Not Recruiting

Personalized PRRT of Neuroendocrine Tumors

NCT02754297

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +8 more
Locations: CHU de Québec - Université Laval Québec, Quebec, Canada

View Trial Details

Active, Not Recruiting

A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3

NCT04524208

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: Medizinische Universität Wien Vienna, Austria

University Medical Center Göttingen Göttingen, Lower Saxony, Germany

Zentralklinik Bad Berka GmbH Bad Berka, Germany

Universitätsklinikum Carl Gustav Carus Dresden, Germany

View all 15 locations

View Trial Details

Active, Not Recruiting

Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

NCT03022188

Conditions: Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +13 more
Locations: Clinique Universitaire Saint Luc Leuven, Belgium

Hopital Sud Amiens, France

CHU Angers Angers, France

CHRU Jean Minjoz Besançon, France

View all 22 locations

View Trial Details

Active, Not Recruiting

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

NCT03044977

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: Holden Comprehensive Cancer Center Iowa City, Iowa, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors

Personalized PRRT of Neuroendocrine Tumors

A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3

Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Related conditions